Period,symbol,NAV,sharesOutstanding,researchDevelopment,effectOfAccountingCharges,incomeBeforeTax,minorityInterest,netIncome,sellingGeneralAdministrative,grossProfit,ebit,operatingIncome,otherOperatingExpenses,interestExpense,extraordinaryItems,nonRecurring,otherItems,incomeTaxExpense,totalRevenue,totalOperatingExpenses,costOfRevenue,totalOtherIncomeExpenseNet,discontinuedOperations,netIncomeFromContinuingOps,netIncomeApplicableToCommonShares,intangibleAssets,capitalSurplus,totalLiab,totalStockholderEquity,otherCurrentLiab,totalAssets,commonStock,otherCurrentAssets,retainedEarnings,otherLiab,goodWill,treasuryStock,otherAssets,cash,totalCurrentLiabilities,shortLongTermDebt,otherStockholderEquity,propertyPlantEquipment,totalCurrentAssets,netReceivables,longTermDebt,inventory,accountsPayable,deferredLongTermAssetCharges,changeToLiabilities,totalCashflowsFromInvestingActivities,netBorrowings,totalCashFromFinancingActivities,changeToOperatingActivities,issuanceOfStock,changeInCash,repurchaseOfStock,effectOfExchangeRate,totalCashFromOperatingActivities,depreciation,changeToInventory,changeToAccountReceivables,otherCashflowsFromFinancingActivities,changeToNetincome,capitalExpenditures,otherCashflowsFromInvestingActivities,WC,language,region,quoteType,triggerable,quoteSourceName,postMarketChangePercent,postMarketTime,postMarketPrice,postMarketChange,regularMarketChangePercent,regularMarketDayRange,ask,bid,regularMarketPreviousClose,bidSize,askSize,messageBoardId,fullExchangeName,longName,financialCurrency,averageDailyVolume3Month,averageDailyVolume10Day,fiftyTwoWeekLowChange,fiftyTwoWeekLowChangePercent,fiftyTwoWeekRange,fiftyTwoWeekHighChange,fiftyTwoWeekHighChangePercent,fiftyTwoWeekLow,fiftyTwoWeekHigh,earningsTimestamp,earningsTimestampStart,earningsTimestampEnd,currency,marketState,regularMarketPrice,regularMarketTime,regularMarketChange,regularMarketOpen,regularMarketDayHigh,regularMarketDayLow,regularMarketVolume,market,priceHint,exchangeDataDelayedBy,twoHundredDayAverageChangePercent,shortName,exchange,epsTrailingTwelveMonths,epsForward,epsCurrentYear,priceEpsCurrentYear,bookValue,fiftyDayAverage,fiftyDayAverageChange,fiftyDayAverageChangePercent,twoHundredDayAverage,twoHundredDayAverageChange,marketCap,forwardPE,priceToBook,sourceInterval,exchangeTimezoneName,exchangeTimezoneShortName,gmtOffSetMilliseconds,esgPopulated,tradeable,Beta (5Y Monthly),52-Week Change 3,S&P500 52-Week Change 3,52 Week High 3,52 Week Low 3,50-Day Moving Average 3,200-Day Moving Average 3,Avg Vol (3 month) 3,Avg Vol (10 day) 3,Shares Outstanding 5,Implied Shares Outstanding 6,Float,% Held by Insiders 1,% Held by Institutions 1,"Shares Short (Apr 29, 2021) 4","Short Ratio (Apr 29, 2021) 4","Short % of Float (Apr 29, 2021) 4","Short % of Shares Outstanding (Apr 29, 2021) 4","Shares Short (prior month Mar 30, 2021) 4",Forward Annual Dividend Rate 4,Forward Annual Dividend Yield 4,Trailing Annual Dividend Rate 3,Trailing Annual Dividend Yield 3,5 Year Average Dividend Yield 4,Payout Ratio 4,Dividend Date 3,Ex-Dividend Date 4,Last Split Factor 2,Last Split Date 3,Fiscal Year Ends,Most Recent Quarter (mrq),Profit Margin,Operating Margin (ttm),Return on Assets (ttm),Return on Equity (ttm),Revenue (ttm),Revenue Per Share (ttm),Quarterly Revenue Growth (yoy),Gross Profit (ttm),EBITDA,Net Income Avi to Common (ttm),Diluted EPS (ttm),Quarterly Earnings Growth (yoy),Total Cash (mrq),Total Cash Per Share (mrq),Total Debt (mrq),Total Debt/Equity (mrq),Current Ratio (mrq),Book Value Per Share (mrq),Operating Cash Flow (ttm),Levered Free Cash Flow (ttm),index,zip,sector,fullTimeEmployees,compensationRisk,auditRisk,longBusinessSummary,city,phone,state,shareHolderRightsRisk,compensationAsOfEpochDate,governanceEpochDate,boardRisk,country,website,maxAge,overallRisk,address1,fax,industry,address2
t0,HBIO,-12992000.0,39927300,2487000,,-684000,,-669000,11166000,15431000,314000,314000,,-411000,,,,-15000,26989000,26675000,11558000,-998000,,-669000,-669000,31888000.0,234781000.0,74134000.0,77115000.0,7129000.0,151249000.0,448000.0,3658000.0,-133055000.0,4657000.0,58219000.0,-25059000.0,812000.0,5815000.0,20718000.0,1970000.0,-14391000.0,11107000.0,49223000.0,17074000.0,41600000.0,22676000.0,6416000.0,,-380000.0,-301000.0,-4500000.0,-3141000.0,-790000.0,1924000.0,-2502000.0,-464000.0,-97000.0,1037000.0,1909000.0,-602000.0,584000.0,-101000.0,915000.0,-151000.0,,28505000.0,en-US,US,EQUITY,True,Nasdaq Real Time Price,0.0,1630526411,8.29,0.0,0.3631929,8.06 - 8.3065,0.0,0.0,8.26,8,10,finmb_598656,NasdaqGM,"Harvard Bioscience, Inc.",USD,219928,166585,5.55,2.0255475,2.74 - 8.75,-0.46000004,-0.052571435,2.74,8.75,1620304200,1635942600,1636374600,USD,PREPRE,8.29,1630526403,0.029999733,8.25,8.3065,8.06,239264,us_market,2,0,0.19476156,"Harvard Bioscience, Inc.",NGM,-0.202,0.35,0.29,28.586208,1.946,8.022572,0.2674284,0.033334497,6.938623,1.351377,330997312,23.685715,4.2600207,15,America/New_York,EDT,-14400000,False,False,1.77,,,8.75,2.74,8.02,6.94,219.93k,166.59k,39.93M,,35.78M,10.98%,73.84%,798.2k,3.49,2.08%,2.00%,816.47k,,,,,,0.00%,,,1319:1000,"Nov 03, 2013","Dec 30, 2020","Mar 30, 2021",-3.76%,2.76%,1.18%,-5.18%,105.32M,2.70,13.50%,58.04M,10.54M,-3.96M,-0.20,,5.82M,0.15,52.79M,68.46,2.38,1.95,7.5M,7.94M,Value,01746,Healthcare,428,4,3,"Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development. It offers physiology, cell, and molecular instruments, such as syringe and peristaltic pump products, as well as a range of instruments and accessories for tissue and organ based lab research, including surgical products, infusion systems, and behavior research systems; and spectrophotometers, microplate readers, amino acid analyzers, gel electrophoresis equipment, and electroporation and electrofusion instruments. The company also engages in the development and manufacture of precision scientific measuring instrumentation and equipment, which cover data acquisition systems with custom amplifier configurations for cellular analysis, micro electrode array solutions for in vivo recordings, and vitro-systems for extracellular recordings; and offers preclinical products, systems, services, and solutions with a focus on physiologic monitoring solutions. It markets its products through sales organizations, websites, catalogs, and distributors to research scientists in pharmaceutical and biotechnology companies, universities, hospitals, and government laboratories, as well as to contract research organizations, academic labs, and government researchers. The company primarily sells its products under Harvard Apparatus, Biochrom, Hoefer, Panlab, Warner Instruments, Hugo Sachs Elektronik, Scie-Plas, BTX, Multi Channel Systems, HEKA, DSI, Ponemah, and Buxco brand names in North America, Europe, China, and internationally. Harvard Bioscience, Inc. was founded in 1901 and is headquartered in Holliston, Massachusetts.",Holliston,508 893 8999,MA,7,1609372800,1619740800,7,United States,http://www.harvardbioscience.com,86400,6,84 October Hill Road,508 429 5732,Medical Instruments & Supplies,Suite 10
t-1,HBIO,-15060000.0,39927300,2349000,,-548000,,-615000,13046000,17708000,861000,861000,,-1094000,,,,67000,30984000,30123000,13276000,-1409000,,-615000,-615000,33151000.0,232357000.0,79573000.0,76681000.0,7056000.0,156254000.0,444000.0,3355000.0,-132386000.0,4753000.0,58590000.0,-23734000.0,1092000.0,8317000.0,21053000.0,1721000.0,-13066000.0,11721000.0,51700000.0,17766000.0,46286000.0,22262000.0,5972000.0,255000.0,42000.0,-314000.0,5039000.0,3357000.0,1582000.0,215000.0,5511000.0,-464000.0,-22000.0,2490000.0,1921000.0,924000.0,-3700000.0,-1897000.0,1553000.0,-64000.0,-250000.0,30647000.0,en-US,US,EQUITY,True,Nasdaq Real Time Price,0.0,1630526411,8.29,0.0,0.3631929,8.06 - 8.3065,0.0,0.0,8.26,8,10,finmb_598656,NasdaqGM,"Harvard Bioscience, Inc.",USD,219928,166585,5.55,2.0255475,2.74 - 8.75,-0.46000004,-0.052571435,2.74,8.75,1620304200,1635942600,1636374600,USD,PREPRE,8.29,1630526403,0.029999733,8.25,8.3065,8.06,239264,us_market,2,0,0.19476156,"Harvard Bioscience, Inc.",NGM,-0.202,0.35,0.29,28.586208,1.946,8.022572,0.2674284,0.033334497,6.938623,1.351377,330997312,23.685715,4.2600207,15,America/New_York,EDT,-14400000,False,False,1.77,,,8.75,2.74,8.02,6.94,219.93k,166.59k,39.93M,,35.78M,10.98%,73.84%,798.2k,3.49,2.08%,2.00%,816.47k,,,,,,0.00%,,,1319:1000,"Nov 03, 2013","Dec 30, 2020","Mar 30, 2021",-3.76%,2.76%,1.18%,-5.18%,105.32M,2.70,13.50%,58.04M,10.54M,-3.96M,-0.20,,5.82M,0.15,52.79M,68.46,2.38,1.95,7.5M,7.94M,Value,01746,Healthcare,428,4,3,"Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development. It offers physiology, cell, and molecular instruments, such as syringe and peristaltic pump products, as well as a range of instruments and accessories for tissue and organ based lab research, including surgical products, infusion systems, and behavior research systems; and spectrophotometers, microplate readers, amino acid analyzers, gel electrophoresis equipment, and electroporation and electrofusion instruments. The company also engages in the development and manufacture of precision scientific measuring instrumentation and equipment, which cover data acquisition systems with custom amplifier configurations for cellular analysis, micro electrode array solutions for in vivo recordings, and vitro-systems for extracellular recordings; and offers preclinical products, systems, services, and solutions with a focus on physiologic monitoring solutions. It markets its products through sales organizations, websites, catalogs, and distributors to research scientists in pharmaceutical and biotechnology companies, universities, hospitals, and government laboratories, as well as to contract research organizations, academic labs, and government researchers. The company primarily sells its products under Harvard Apparatus, Biochrom, Hoefer, Panlab, Warner Instruments, Hugo Sachs Elektronik, Scie-Plas, BTX, Multi Channel Systems, HEKA, DSI, Ponemah, and Buxco brand names in North America, Europe, China, and internationally. Harvard Bioscience, Inc. was founded in 1901 and is headquartered in Holliston, Massachusetts.",Holliston,508 893 8999,MA,7,1609372800,1619740800,7,United States,http://www.harvardbioscience.com,86400,6,84 October Hill Road,508 429 5732,Medical Instruments & Supplies,Suite 10
t-2,HBIO,-14795000.0,39927300,1949000,,-1415000,,-1098000,9668000,13495000,501000,501000,,-1205000,,,,-317000,24037000,23536000,10542000,-1916000,,-1098000,-1098000,34315000.0,231142000.0,72447000.0,77167000.0,7073000.0,149614000.0,438000.0,4146000.0,-131771000.0,2269000.0,57647000.0,-22642000.0,1896000.0,2806000.0,21248000.0,2807000.0,-11974000.0,12236000.0,43520000.0,13879000.0,41238000.0,22689000.0,5990000.0,,-689000.0,-564000.0,-340000.0,-953000.0,-819000.0,215000.0,177000.0,-613000.0,97000.0,1597000.0,1848000.0,863000.0,950000.0,-1897000.0,685000.0,-564000.0,-250000.0,22272000.0,en-US,US,EQUITY,True,Nasdaq Real Time Price,0.0,1630526411,8.29,0.0,0.3631929,8.06 - 8.3065,0.0,0.0,8.26,8,10,finmb_598656,NasdaqGM,"Harvard Bioscience, Inc.",USD,219928,166585,5.55,2.0255475,2.74 - 8.75,-0.46000004,-0.052571435,2.74,8.75,1620304200,1635942600,1636374600,USD,PREPRE,8.29,1630526403,0.029999733,8.25,8.3065,8.06,239264,us_market,2,0,0.19476156,"Harvard Bioscience, Inc.",NGM,-0.202,0.35,0.29,28.586208,1.946,8.022572,0.2674284,0.033334497,6.938623,1.351377,330997312,23.685715,4.2600207,15,America/New_York,EDT,-14400000,False,False,1.77,,,8.75,2.74,8.02,6.94,219.93k,166.59k,39.93M,,35.78M,10.98%,73.84%,798.2k,3.49,2.08%,2.00%,816.47k,,,,,,0.00%,,,1319:1000,"Nov 03, 2013","Dec 30, 2020","Mar 30, 2021",-3.76%,2.76%,1.18%,-5.18%,105.32M,2.70,13.50%,58.04M,10.54M,-3.96M,-0.20,,5.82M,0.15,52.79M,68.46,2.38,1.95,7.5M,7.94M,Value,01746,Healthcare,428,4,3,"Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development. It offers physiology, cell, and molecular instruments, such as syringe and peristaltic pump products, as well as a range of instruments and accessories for tissue and organ based lab research, including surgical products, infusion systems, and behavior research systems; and spectrophotometers, microplate readers, amino acid analyzers, gel electrophoresis equipment, and electroporation and electrofusion instruments. The company also engages in the development and manufacture of precision scientific measuring instrumentation and equipment, which cover data acquisition systems with custom amplifier configurations for cellular analysis, micro electrode array solutions for in vivo recordings, and vitro-systems for extracellular recordings; and offers preclinical products, systems, services, and solutions with a focus on physiologic monitoring solutions. It markets its products through sales organizations, websites, catalogs, and distributors to research scientists in pharmaceutical and biotechnology companies, universities, hospitals, and government laboratories, as well as to contract research organizations, academic labs, and government researchers. The company primarily sells its products under Harvard Apparatus, Biochrom, Hoefer, Panlab, Warner Instruments, Hugo Sachs Elektronik, Scie-Plas, BTX, Multi Channel Systems, HEKA, DSI, Ponemah, and Buxco brand names in North America, Europe, China, and internationally. Harvard Bioscience, Inc. was founded in 1901 and is headquartered in Holliston, Massachusetts.",Holliston,508 893 8999,MA,7,1609372800,1619740800,7,United States,http://www.harvardbioscience.com,86400,6,84 October Hill Road,508 429 5732,Medical Instruments & Supplies,Suite 10
t-3,HBIO,-16385000.0,39927300,1897000,,-868000,,-1581000,9949000,13856000,556000,556000,,-1233000,,,,713000,23308000,22752000,9452000,-1424000,,-1581000,-1581000,35495000.0,230675000.0,74617000.0,76068000.0,7109000.0,150685000.0,438000.0,3582000.0,-130673000.0,2485000.0,56958000.0,-24372000.0,1743000.0,2629000.0,22663000.0,2807000.0,-13704000.0,12387000.0,44102000.0,14710000.0,41582000.0,23181000.0,6596000.0,,-92000.0,-283000.0,-5467000.0,-5300000.0,-441000.0,167000.0,-3253000.0,-613000.0,-43000.0,2373000.0,1952000.0,39000.0,706000.0,-1897000.0,1354000.0,-283000.0,-250000.0,21439000.0,en-US,US,EQUITY,True,Nasdaq Real Time Price,0.0,1630526411,8.29,0.0,0.3631929,8.06 - 8.3065,0.0,0.0,8.26,8,10,finmb_598656,NasdaqGM,"Harvard Bioscience, Inc.",USD,219928,166585,5.55,2.0255475,2.74 - 8.75,-0.46000004,-0.052571435,2.74,8.75,1620304200,1635942600,1636374600,USD,PREPRE,8.29,1630526403,0.029999733,8.25,8.3065,8.06,239264,us_market,2,0,0.19476156,"Harvard Bioscience, Inc.",NGM,-0.202,0.35,0.29,28.586208,1.946,8.022572,0.2674284,0.033334497,6.938623,1.351377,330997312,23.685715,4.2600207,15,America/New_York,EDT,-14400000,False,False,1.77,,,8.75,2.74,8.02,6.94,219.93k,166.59k,39.93M,,35.78M,10.98%,73.84%,798.2k,3.49,2.08%,2.00%,816.47k,,,,,,0.00%,,,1319:1000,"Nov 03, 2013","Dec 30, 2020","Mar 30, 2021",-3.76%,2.76%,1.18%,-5.18%,105.32M,2.70,13.50%,58.04M,10.54M,-3.96M,-0.20,,5.82M,0.15,52.79M,68.46,2.38,1.95,7.5M,7.94M,Value,01746,Healthcare,428,4,3,"Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development. It offers physiology, cell, and molecular instruments, such as syringe and peristaltic pump products, as well as a range of instruments and accessories for tissue and organ based lab research, including surgical products, infusion systems, and behavior research systems; and spectrophotometers, microplate readers, amino acid analyzers, gel electrophoresis equipment, and electroporation and electrofusion instruments. The company also engages in the development and manufacture of precision scientific measuring instrumentation and equipment, which cover data acquisition systems with custom amplifier configurations for cellular analysis, micro electrode array solutions for in vivo recordings, and vitro-systems for extracellular recordings; and offers preclinical products, systems, services, and solutions with a focus on physiologic monitoring solutions. It markets its products through sales organizations, websites, catalogs, and distributors to research scientists in pharmaceutical and biotechnology companies, universities, hospitals, and government laboratories, as well as to contract research organizations, academic labs, and government researchers. The company primarily sells its products under Harvard Apparatus, Biochrom, Hoefer, Panlab, Warner Instruments, Hugo Sachs Elektronik, Scie-Plas, BTX, Multi Channel Systems, HEKA, DSI, Ponemah, and Buxco brand names in North America, Europe, China, and internationally. Harvard Bioscience, Inc. was founded in 1901 and is headquartered in Holliston, Massachusetts.",Holliston,508 893 8999,MA,7,1609372800,1619740800,7,United States,http://www.harvardbioscience.com,86400,6,84 October Hill Road,508 429 5732,Medical Instruments & Supplies,Suite 10
